Nuveen Asset Management, LLC Infinity Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $257,267 - $630,043	-525,036 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.85 - $2.4 $549 - $1,552	647 Added 0.12%	525,036 $521,000
Q4 2021 Feb 14, 2022	BUY	$1.86 - $3.36 $514,250 - $928,969	276,479 Added 111.52%	524,389 $1.18 Million
Q3 2021 Nov 12, 2021	SELL	$1.52 - $3.82 $8,940 - $22,469	-5,882 Reduced 2.32%	247,910 $900,000
Q2 2021 Aug 16, 2021	BUY	$2.66 - $3.47 $675,086 - $880,658	253,792 New	253,792 $759,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.